In our library, you can discover the webinars that took place since 2019. The webinars were broadcasted in English and Russian. Choose your language and experience what experts from all over the world discussed for the hot topics in various therapeutic areas.
CONSISTENCY BETWEEN EFFICACY AND EFFECTIVENESS OF BIOLOGICS IN SEVERE EOSINOPHILIC ASTHMA
YIN AND YANG OF EOSINOPHILS & RATIONALE FOR ANTI-IL-5 APPROACHES IN EOSINOPHILIC DISORDER
REMISSION – AN AMBITIOUS TREATMENT GOAL INSPIRED BY RHEUMATOID ARTHRITIS
REMISSION IN SEA – 2024 UPDATES
COMBINED Q&A SESSION 01
PRACTICAL CHALLENGES IN SEA MANAGEMENT – INSIGHTS FROM A PATIENT ASSOCIATION
BEST PRACTICES OF OVERCOMING PATIENT ACCESS CHALLENGES IN SEA IN BULGARIA
BEST PRACTICES OF OVERCOMING PATIENT ACCESS CHALLENGES IN SEA IN LITHUANIA
BEST PRACTICES OF OVERCOMING PATIENT ACCESS CHALLENGES IN SEA HUNGARY
COMBINED Q&A SESSION 02
SEA AND ITS COMORBIDITIES – EFFICACY ACROSS INDICATIONS
SPECIAL GUEST LECTURE EGPA: CONSISTENCY IN REMISSION INDUCTION ACROSS INDICATIONS
SPECIAL GUEST LECTURE HES: CONSISTENCY IN EFFICACY ACROSS INDICATIONS
COMBINED Q&A SESSION 03
DUAL BRONCHO-DILATATION TREATMENT – THE OPTIMAL WAY TO START
IS THERE STILL A PLACE FOR MONOTHERAPY? IMPORTANCE OF COPD EARLIER DIAGNOSIS
COMBINED Q&A SESSION 04
WHY AND HOW TO ESCALATE TO TRIPLE THERAPIES
IMPORTANCE OF EARLIER SINGLE-INHALER TRIPLE THERAPY INTERVENTION AFTER EXACERBATION
COMBINED Q&A SESSION 05
MORTALITY REDUCTION IN COPD
COPD AND ITS COMORBIDITIES: HOW TO FILL THE EVIDENCE GAPS?
DO WE NEED AND HOW TO DE-ESCALATE PATIENTS ON TRIPLES?
INSPIRATION FLOW AND DRUG DEPOSITION IN THE LUNG: ARE THEY WORTH TO BE CONSIDERED?
COMBINED Q&A SESSION 06
TRIPLE THERAPY. ARE ALL THE SITT THE SAME?
COMBINED Q&A SESSION 07
Live polling to vote will be available for all participants.
The webinar applied for 1 CME credit at the Royal College of Physicians RCP.
Dave Singh is Professor of Clinical Pharmacology & Respiratory Medicine at the University of Manchester.
After graduating in medicine at Cambridge University, he specialized in clinical pharmacology and respiratory medicine.
The development of new drugs for asthma and COPD is his primary interest of research.
• Member of the Global initiative for the management of chronic Obstructive Lung Disease (GOLD) Science Committee
• Chair of the European Respiratory Society airway pharmacology group
• An Editor of the British Journal of Clinical Pharmacology, of the European Respiratory Journal.
Management of Chronic Coronary Syndromes
